Search filters

List of works by Markus Vähä-Koskela

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

scientific article published on 30 June 2016

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor

scientific article

Cancer-targeted oncolytic adenoviruses for modulation of the immune system

scientific article published on 2 May 2017

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

scientific article

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

scientific article published on 27 August 2015

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".

scientific article published in November 2016

Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

scientific article published on 10 January 2017

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models

scientific article published on August 2007

Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors

scientific article published on 24 June 2015

GMCSF-armed vaccinia virus induces an antitumor immune response

scientific article published on 10 July 2014

Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas

scientific article published on 3 August 2017

Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2.

scientific article published on 4 November 2015

Incomplete but infectious vaccinia virions are produced in the absence of oncolysis in feline SCCF1 cells

scientific article published on 23 March 2015

Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models

scientific article

MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma

scientific article

MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver

scientific article

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma

scientific article

Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance.

scientific article published on 4 November 2015

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy

scientific article published on September 2012

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

scientific article published on 7 January 2015

PROX1 is a transcriptional regulator of MMP14.

scientific article published on 22 June 2018

Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity

scientific article

Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains

scientific article published in January 2012

Replication competent Semliki Forest virus prolongs survival in experimental lung cancer

scientific article

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles

scientific article published on 10 December 2014

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

scientific article published on 18 February 2016

T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma

scientific article published on November 2016

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

scientific article

Tumor Restrictions to Oncolytic Virus

scientific article published on 17 April 2014

Paulina is supported by:

About Paulina

Help